Skip to main content


Implementing Contingency Management for Stimulant Use in Specialty Addiction Treatment Organizations

MIMIC2 is part of a NIDA Center of Excellence focused on advancing equitable access to effective addiction treatment. The project addresses one of the largest evidence-to-practice gaps in the addiction treatment field: the gap between the wealth of evidence supporting contingency management for stimulant use and its lack of availability in community settings.

Contingency management (CM) is the most effective intervention for stimulant use, but its uptake in specialty addiction programs is notoriously low. This type 3 hybrid effectiveness-implementation trial evaluates whether a multi-level, well-specified implementation strategy (Science to Service Laboratory [SSL]) can promote the uptake of CM for stimulant use in specialty addiction treatment. Utilizing a stepped wedge design, a regional cohort of 10 public sector clinics will be randomized to receive the SSL at five distinct time points. At six intervals, each of the 10 clinics will provide data from all available patient charts on CM delivery and patient outcomes. In addition, staff from each clinic will report on contextual determinants of implementation outcomes. The study will advance the scientific aims of the Center of Excellence by specifying and closely tracking delivery of the implementation strategy, while exploring the mediating influence of contextual determinants on implementation outcomes.  

Project Details

  • Dates: July 2022 – May 2027
  • Funding source: National Institute on Drug Abuse
  • Grant number: P50DA054072